The NSW Opioid Treatment Program (OTP) seeks to reduce the social, economic and health harms associated with opioid use. The OTP delivers pharmacotherapy and associated services to opioid dependent patients in NSW. 

To enrol a patient on the NSW OTP, authorisation from the NSW Ministry of Health is required. Forms to apply for authorisation are provided on this page - see OTP Forms.

Refer to NSW clinical guidelines: Treatment of opioid dependence - 2018 for further information. 

For assistance or further information contact the OTP section at Pharmaceutical Regulatory Unit during business hours on (02) 9424 5921.


OTP notifications


OTP forms

To apply for authorisation to prescribe methadone or buprenorphine (including buprenorphine-naloxone) for the NSW Opioid Treatment Program, and exit patients from a Program use the forms:

The forms are formatted in the State Health Record Form template. Previous OTP forms (dated 05/18) may also be submitted.

Specialist advisory line

Contact NSW Drug & Alcohol Specialist Advisory Services (DASAS) on (02) 9361 8006 in Sydney metropolitan areas or 1800 023 687 in NSW regional/rural areas for clinical advice on the diagnosis and clinical management of patients with alcohol or other drug related problems

Interstate transfers

Non-accredited prescribers

Medical and nurse practitioners must successfully complete the Fundamentals of Training and Opioid Treatment Accreditation Course (OTAC) to become an accredited OTP prescriber in NSW.

A NSW medical practitioner who has not received accreditation as a NSW OTP prescriber may be authorised by the Ministry of Health to manage up to 30 patients including:
  • maximum of 10 patients treated with methadone who are referred by an accredited OTP prescriber.
  • maximum of 20 patients treated with buprenorphine or buprenorphine-naloxone, who may be inducted by a non-accredited prescriber or referred by an accredited OTP prescriber.

Non-accredited prescribers are encouraged to complete the free online Fundamentals Training course to ensure they understand the requirements for prescribing opioid pharmacotherapy for patients.

Authorisation to prescribe methadone or buprenorphine (including buprenorphine-naloxone) must be granted by the Ministry of Health before a prescription may be issued to commence treatment. Forms to apply for authorisation are provided on this page - see OTP Forms.
Page Updated: Friday 26 July 2019
Contact page owner: Pharmaceutical Services